PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-932

OK , the merry go round of 8.2 to 8.4 needs to be kicked to the curb...

The ping pong game looks to have been completed with a move to 8.6,,, maybe today we can pull away from this drudgery of 8c and climb back up into double digits.

There is a swag of investors who just wont touch a Penny Dreadful ( under 10c) so Holders if you want to see a higher SP then the power is in your hands,,, buyers cant buy what doesnt exist.... 10c should be our new bottom and then we can start the build up to get those oppies in the money..

Circa $14m in oppies , keeps all the shares inhouse with current holders...

JP have released a great report but Management need to keep up momentum ,, "First Patient dosed for MND" should be shouted from the rooftops..
Being the first MPL Tablet in a Human in 6 years is a serious milestone and needs to be broadcast and celebrated by the company..

August next week..................................................................................

First dosed will bring an ASX announcement as it unlocks another installment of the trial funds provided by MND.

Yard work for me today , rivers are flooded from a week of rain and the snow has topped all the mountains out front of my place.

Its bloody cold...............looks sunny but a breeze could cut through you like a knife,,, thermals are a must